Assertio Holdings, Inc. (ASRT)
Pharmaceutical Preparations
Latest Price
$23.50
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
11.76
P/B Ratio
2.00
Valuation metrics
adjust assumptions →Base FCF: $38M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$28.78
+22% upside
Institutional Ownership
38.5% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 692.3K | $13.0M | 10.74% | +105.0K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 269.0K | $5.0M | 4.17% | -- | 2026-03-31 |
| Opaleye Management Inc. | 265.7K | $5.0M | 4.12% | -- | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 228.6K | $4.0M | 3.55% | +37.9K | 2026-03-31 |
| EDGEWOOD MANAGEMENT LLC | 107.5K | $2.0M | 1.67% | -1 | 2026-03-31 |
| BlackRock, Inc. | 90.0K | $1.0M | 1.40% | +1 | 2026-03-31 |
| JANE STREET GROUP, LLC | 79.4K | $1.0M | 1.23% | +67.6K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 76.3K | $1.0M | 1.18% | +7.2K | 2026-03-31 |
| CITADEL ADVISORS LLC | 74.6K | $1.0M | 1.16% | +18.2K | 2026-03-31 |
| Walleye Capital LLC | 65.9K | $1.0M | 1.02% | -- | 2026-03-31 |